Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2014


World ADC San Diego

26 Oct 2014 - 29 Oct 2014 - San Diego, CA, USA



Bookmark and Share


World ADC San Diego has been designed to dramatically enhance your ADC research and development efforts. Providing access to expert intelligence on how to select your lead candidate with confidence, improve preclinical predictability and maximize clinical efficacy, the 2014 program cannot be missed.

This year, 65+ amazing speakers and over 550 of the global network of ADC developers will distill 12 months of learning into 4 jam packed days of insight and intelligence. Join us to improve your programs and be part of the mission to develop better ADC drugs

Our final early registration discounts expire September 12th. This is both delegates final chance to save money on their registration fees, but also their chance to get priority access to a number of tools that will help them to maximise their time on site. 

Only delegates registered by the 12th, will get access at that time to our networking app so they can see who will be attending the event; to ‘My World ADC’, a special delegate area on our website with instructions, tips etc. about how best to prepare, as well as priority registration to the World ADC Awards Similarly any content is available at: http://adc-summit.com/content-library. We have a number of articles from Genentech, an interview with Robert Hollingsworth, Senior Director at MedImmune etc. 









Further information
Scientific News
Cell Transplant Treats Parkinson’s in Mice
A University of Wisconsin—Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell.
Understanding Female HIV Transmission
Glowing virus maps points of entry through entire female reproductive tract for first time.
Experimental Drug Cancels Effect from Key Intellectual Disability Gene
A University of Wisconsin—Madison researcher who studies the most common genetic intellectual disability has used an experimental drug to reverse — in mice — damage from the mutation that causes the syndrome.
Common Class of Cancer Drugs May Not Lead to Cognitive Decline
UCLA study refutes 2015 research suggesting anthracyclines could cause memory loss, other impairments.
Designing Better Drugs
A rational drug engineering approach could breathe new life into drug development.
Genetic Approach May Lead to New Treatments for Digestive Diseases
Researchers at UMass Medical School have identified a new molecular pathway critical for maintaining the smooth muscle tone that allows the passage of materials through the digestive system.
Potential Target for Revolutionary Antibiotics
An international team of including the Lomonosov Moscow State University researchers discovered which enzyme enables Escherichia coli bacterium (E. coli) to breathe.
Unique Model for Studying ALS
Unique mouse model will allow researchers to better study the genetic origins and potential treatments of ALS.
Factors Influencing Influenza Vaccine Effectiveness Uncovered
The long-held approach to predicting seasonal influenza vaccine effectiveness may need to be revisited, new research suggests.
New Model to Enhance Zika Virus Research
The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!